What You Should Know: - Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. IBF and Peregrine Ventures led the round, with participation from aMoon Fund and other existing investors. - The funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company’s pipeline of
Read More
Clinical Trial
Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M
What You Should Know: - Florence HealthcareTM, a clinical research technology company headquartered in Atlanta, Georgia, recently announced the completion of a year-long third-party study on the impact of Site Enablement PlatformsTM on clinical research timelines and costs. - The study by Marketcap Consulting is the first to compare how traditional site management approaches differ from site-first Site Enablement Platforms. The study looked at the impact of traditional sponsor
Read More
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know: - Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
Brain Health: The Next Frontier in the Fight Against Dementia
There are differing views on the value of cognitive screening of older adults in a primary care setting. Many providers point to the lack of disease-modifying treatments for Alzheimer’s Dementia and related dementias (ADRD) as a reason to not universally screen older adults for cognitive deficits. If I don’t have anything to give my patients to get better, what’s the point in revealing they might be at risk of dementia, or that they have early disease? Is dementia a ‘normal’ or ‘expected’ part
Read More
Why Data is at the Heart of Value-Based Care Success
The saying “you cannot manage what you cannot measure” applies to all aspects of healthcare delivery, but it is especially true in value-based care. After all, payers, providers, and the patients they care for need to know what high-value care looks like at an individual level – and how it can be applied at the population level. Delivery and technology infrastructure. All too often, data is captured in disparate systems, forcing administrative staff – or, worse, physicians and nurses – to
Read More
Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals
What You Should Know: - In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color. - However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers
Read More
Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures
What You Should Know: - The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’s immersive virtual reality software. - The results of the trial showed that the majority of patients (13/17) using the XRHealth VR technology did not need
Read More
Children’s Oncology Group Taps Tempus to Provide Genomic Sequencing for Pediatric Cancer Patients
What You Should Know: -Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Epic Launches Life Sciences Program with Clinical Trial Matchmaking
What You Should Know: - Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare. - The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies. Unifying Clinical Research with Care Delivery Providers across the world use Epic to
Read More
